Physician profile
Luca Giliberto
NPI 1891082632
$12,465.61
in general payments reported to CMS, 2019-2025
4 companies · $8,135 in 2025
The $8,135 reported for 2025 was more than what 92% of Behavioral Neurology & Neuropsychiatry providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.79 · 2020: $1,600 · 2022: $1,695 · 2024: $960 · 2025: $8,135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,946 · Travel and Lodging: $1,906 · Honoraria: $960 · Food and Beverage: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,946.25 |
| Travel and Lodging | $1,906.04 |
| Honoraria | $960.00 |
| Food and Beverage | $282.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $8,134.82 | 2025 | |
| Biogen, INC. | $3,295.00 | 2020-2022 | |
| Lundbeck LLC | $960.00 | 2024 | Rexulti |
| Eisai INC. | $75.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luca Giliberto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.